major-depressive-disorder

Documents about major-depressive-disorder

• Resting-state fMRI-based machine learning for predicting SSRI treatment response in major depressive disorder.#434142NCBI PubMed Central
• Incomplete network restoration may be associated with higher relapse risk in women with major depressive disorder.#439198NCBI PubMed Central
• A Decision-Support System to Personalize Antidepressant Treatment in Major Depressive Disorder: A Randomized Clinical Trial.#645480NCBI PubMed Central
• Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis#715389PhilArchive
• Functional electrical stimulation for major depressive disorder: Protocol for a pilot randomized controlled trial.#785429NCBI PubMed Central
• The Experience of Older Adults Facing Depression for the First Time in Old Age#829074ClinicalTrials.gov
• Neural Correlates of Stress and Perceived Control in Adolescent Depression#847984ClinicalTrials.gov
• Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression#848905ClinicalTrials.gov
• Depression, Epinephrine, and Platelet Function#851807ClinicalTrials.gov
• HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms#866527ClinicalTrials.gov
• Rapid Acting TMS for Suicide Ideation in Depression#874048ClinicalTrials.gov
• RTMS Feasibility Study on Adolescent Depression Stimulation#878375ClinicalTrials.gov
• Establishing TCM Daycare Model and Teaching Mechanism of Depression Patients#885810ClinicalTrials.gov
• Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33#890486ClinicalTrials.gov
• Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD#894372ClinicalTrials.gov
• Model-based Defining of Subtypes of Depression and Optimal Treatment: an Integrated Techniques Module.#898787ClinicalTrials.gov
• Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials#918389ClinicalTrials.gov
• Dichotic Listening as a Predictor of Medication Response in Depression#969753ClinicalTrials.gov
• Mommy-Baby Treatment for Perinatal Depression#981378ClinicalTrials.gov
• Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response#1008500ClinicalTrials.gov
• Illness Severity and Longitudinal Gray Matter Volumes Among People With Major Depressive Disorder#1028828Bielefeld Pub
• Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression#1044183ClinicalTrials.gov
• Universum Inspired Graph Contrast Learning for Major Depressive Disorder Identification: In Functional Brain Network View.#1054310NCBI PubMed Central
• Genetic risk for major depressive disorder and loneliness in sex-specific associations with coronary artery disease#620046eScholarship
• Increased prevalence of white matter hyperintensities in patients with panic disorder#326593KOASAS: KAIST Open Access Self-Archiving System
• Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents#828355ClinicalTrials.gov
• The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)#918188ClinicalTrials.gov
• Serotonin Variants & Gut Microbiota in Mental Health#831334ClinicalTrials.gov
• Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness#849091ClinicalTrials.gov
• Mindfulness-based Psilocybin Therapy for PTSD#811010ClinicalTrials.gov
• Accelerated TMS to a Novel Brain Target in MDD and PTSD#827209ClinicalTrials.gov
• Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital#873320ClinicalTrials.gov
• Mental Health Assessment and Prescribing by Alberta Pharmacists#979857ClinicalTrials.gov
• Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study#1047053ClinicalTrials.gov
• The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels#862435ClinicalTrials.gov
• Enhancing Veteran-Clinical Collaboration in VA PRRCs#909076ClinicalTrials.gov
• Abilify Therapy for Reducing Comorbid Substance Abuse#895704ClinicalTrials.gov
• Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression#916511ClinicalTrials.gov
• Psilocybin to Treat Depression in Spinal Cord Injury#152542ClinicalTrials.gov
• Decisional reference point pathology: A cognitive mechanism for and a correlate of major depressive disorder in humans.#247820NCBI PubMed Central
• Beyond Infection: The Interplay of Salivary Human Herpesvirus 6, Stress, and Host Factors in Major Depressive Disorder.#317586NCBI PubMed Central
• Interpretable deep learning for functional MRI-based auxiliary diagnosis of major depressive disorder with suicidal ideation.#392765NCBI PubMed Central
• Neurophysiological Correlates of Neuroanatomical Dimensions in Major Depressive Disorder: Electroencephalographic Markers of Brain Function and Treatment Outcome.#396227NCBI PubMed Central
• Clustering of major depressive disorder genetic instruments identifies distinct and directionally opposing effects on cardiometabolic risk#414811Europe PMC
• Association between childhood trauma and 26-week prognosis in adolescents with major depressive disorder: a cohort study.#645249NCBI PubMed Central
• P10 Physical exercise in major depressive disorder: effects on neuroplasticity, cognition and clinical symptoms#657402Bielefeld Pub
• Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients#800782ClinicalTrials.gov
• Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)#801524ClinicalTrials.gov
• Ketamine Versus Electroconvulsive Therapy in Depression#806555ClinicalTrials.gov
• Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms#828521ClinicalTrials.gov